Bristol-Myers Squibb Company (BRM.DE)
Develops medicines to treat cancer, autoimmune diseases, and blood disorders.
55.93-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+48.1%
The outlook
Bristol-Myers Squibb is trading near its 52-week highs, well above both its 50- and 200-day moving averages. The stock carries a trailing P/E of 17.8, and analyst coverage shows a bullish lean based on current market data.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range95% of the way from its 52-week low to high
Market cap
$114.21B
52-wk high
57.02
52-wk low
36.60
50-day avg
50.23
200-day avg
48.00
Trailing P/E
17.8